APA (7th ed.) Citation

Kania, D., Nouhin, J., Bolloré, K., Njouom, R., Toni, T. d., Maiga, A. I., . . . Tuaillon, E. (2024). Development and field evaluation in African and Asian countries of an hepatitis B virus PCR on open polyvalent platforms to determine treatment eligibility: Results from the "Agence Nationale de Recherche sur le Sida et les hépatites" 12327 study. Clinical microbiology and infection, 30(8), 1067. https://doi.org/10.1016/j.cmi.2024.05.002

Chicago Style (17th ed.) Citation

Kania, Dramane, et al. "Development and Field Evaluation in African and Asian Countries of an Hepatitis B Virus PCR on Open Polyvalent Platforms to Determine Treatment Eligibility: Results from the "Agence Nationale De Recherche Sur Le Sida Et Les Hépatites" 12327 Study." Clinical Microbiology and Infection 30, no. 8 (2024): 1067. https://doi.org/10.1016/j.cmi.2024.05.002.

MLA (9th ed.) Citation

Kania, Dramane, et al. "Development and Field Evaluation in African and Asian Countries of an Hepatitis B Virus PCR on Open Polyvalent Platforms to Determine Treatment Eligibility: Results from the "Agence Nationale De Recherche Sur Le Sida Et Les Hépatites" 12327 Study." Clinical Microbiology and Infection, vol. 30, no. 8, 2024, p. 1067, https://doi.org/10.1016/j.cmi.2024.05.002.